PATENT CLAIM ANALYSIS

Application Number: 15743427
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["548", "263200"]

Abstract:
Provided herein are pyrrolomycin derivatives, which can be used to modulate Mcl-1, inhibit proliferation of bacteria and pathogens, as well as to treat infectious diseases and cancers.

Claim (Index 31):
The method of any one of  claims 25 ,  26 , and  28 , wherein the pathogen or bacteria is  Staphylococcus, Enterococcus, Bacillus, Streptococcus, Klebsiella, Acinetobacter, Pseudomonas, Enterobacter, Escherichia, Clostridium, Citrobacter, Serratia, Neisseria, Corynebacterium, Cyanobacterium, Salmonella, Shigella, Helicobacter, Brucella, Borrelia, Bordetella, Bartonella, Bacteroides, Burkholderia, Mycobacterium, Mycoplasma, Campylobacter, Chlamydia, Chlamydophila, Francisella, Haemophilus, Legionella, Leptospira, Listeria, Rickettsia, Vibrio, Ureaplasma, Yersinia, Treponema, Proteus, Stenotrophomonas, Plesiomonas, Nocardia, Actinomyces, Moraxella, Erysipelothrix, Actinobacillus, Anaplasma, Pasteurella, Alcaligenes, Achromobacter,  or  Candida.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.19231
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13836743', '14707197', '13983747', '13984991', '15744922']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.737260418169025
- 35 USC 102 Novelty (BERT): 0.485850116957283
- Combined Prediction Score: 0.7121193880478508
- Mean Citation Score: 218.08078
- Max Citation Score: 222.3453
- Similarity Product: 173.2931284833133

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test